Juerg Lehmann
19Patents
9h-index
37Co-inventors
68Inventor score
Filing activity: Jul 9, 2004 → Apr 14, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7884101B2 | 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | Emerging Cross-Sectional Technologies | 39 | Active |
| US7838525B2 | Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto | Chemistry; Metallurgy | 37 | Active |
| US7470699B2 | Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto | Chemistry; Metallurgy | 29 | Expired |
| US8415484B2 | Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders | Chemistry; Metallurgy | 23 | Active |
| US8580841B2 | Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders | Emerging Cross-Sectional Technologies | 17 | Active |
| US9126932B2 | Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders | Emerging Cross-Sectional Technologies | 15 | Active |
| US8785441B2 | 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | Emerging Cross-Sectional Technologies | 10 | Active |
| US8362248B2 | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto | Chemistry; Metallurgy | 9 | Active |
| US9522133B2 | Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders | Emerging Cross-Sectional Technologies | 9 | Active |
| US9108969B2 | Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders | Chemistry; Metallurgy | 6 | Active |
| US7816364B2 | GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto | Human Necessities | 3 | Active |
| US9676758B2 | 1-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related thereto | Chemistry; Metallurgy | 1 | Active |
| US8101626B2 | GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto | Human Necessities | 1 | Active |
| US8546429B2 | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto | Chemistry; Metallurgy | 0 | Active |
| US10624900B2 | 5-HT2C receptor agonists and compositions and methods of use | Human Necessities | 0 | Active |
| US11395824B2 | 5-HT2C receptor agonists and compositions and methods of use | Human Necessities | 0 | Active |
| US10781180B2 | 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | Emerging Cross-Sectional Technologies | 0 | Active |
| US10894787B2 | Modulators of the GPR119 receptor and the treatment of disorders related thereto | Human Necessities | 0 | Active |
| US10272094B2 | 5-HT2C receptor agonists and compositions and methods of use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.